Related Experiment Videos
Outpatient antidepressant utilization in a Dutch sick fund
K J Gregor1, T R Hylan, P C van Dijk
1Eli Lilly and Company, Indianapolis, IN 46285, USA.
The American Journal of Managed Care
|July 6, 1998
Summary
Patients with depression often received inadequate antidepressant therapy duration and dosage. Concurrent use of anxiolytics or sedative/hypnotics was also observed, indicating potential quality improvement opportunities in depression management.
Area of Science:
- Pharmacotherapy
- Clinical Pharmacy
- Health Services Research
Background:
- Depression management requires adequate antidepressant therapy.
- Concurrent use of anxiolytics or sedative/hypnotics may indicate suboptimal depression treatment.
- Evaluating antidepressant prescribing patterns is crucial for quality improvement.
Purpose of the Study:
- To assess antidepressant therapy patterns, including duration and dosage.
- To evaluate the concurrent use of anxiolytics or sedative/hypnotics with antidepressants.
- To identify quality improvement opportunities in depression management.
Main Methods:
- Retrospective analysis of electronic prescription data from a Dutch sick fund.
- Inclusion of 2,554 patients initiating therapy with amitriptyline, fluoxetine, fluvoxamine, or paroxetine.
- Follow-up periods of 6 months for antidepressant use and 60 days for concurrent medication use.
Main Results:
- Most patients received less than 4 months of antidepressant therapy, particularly with amitriptyline.
- Initial and subsequent antidepressant doses were frequently below recommended therapeutic minimums for depression.
- 18.2% of patients concurrently used anxiolytics or sedative/hypnotics within 60 days of antidepressant initiation.
Conclusions:
- Patients in this cohort likely received suboptimal antidepressant doses and durations compared to Dutch guidelines.
- Findings suggest significant opportunities for quality improvement in depression treatment.
- These results align with previous studies in the Netherlands, Europe, and the US.